Trials / Recruiting
RecruitingNCT06781359
Study on Plasmablastic Lymphoma Patients
An International Multicenter Observational Retrospective Study on Plasmablastic Lymphoma Patients
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Fondazione Italiana Linfomi - ETS · Academic / Other
- Sex
- All
- Age
- 15 Years
- Healthy volunteers
- Not accepted
Summary
This is an observational, multicenter, international and retrospective study, that aims to collect data on clinical and pathological characteristics, treatment regimens, outcome, and prognostic factors (clinical, biomarkers and/or radio-metabolic) in patients affected by PBL.
Detailed description
This study is an International, multicenter, observational, retrospective trial on patients affected by PBL. The information collected aim to obtain data from the real-life diagnosis, staging, management and treatment and outcome of PBL patients. A centralized pathological review of pathological samples is planned to define the rate of accurate diagnosis and to define a recommended immunohistochemical diagnostic panel for PBL. In addition, exploratory analysis will be performed to better characterize PBL.
Conditions
Timeline
- Start date
- 2025-02-14
- Primary completion
- 2028-02-01
- Completion
- 2028-02-01
- First posted
- 2025-01-17
- Last updated
- 2025-12-02
Locations
23 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT06781359. Inclusion in this directory is not an endorsement.